Getting to
the Heart
of HIV
Benefits of REPRIEVE
to Minimize Risk
All participants will receive
guidance on steps to improve
heart health, including:
kely to develop
duals without HIV.
Taking antiretroviral
of heart disease therapy
Keeping cholesterol,
DA. Statins are usedblood
to pressure,
and blood sugar in
good range
sidered safe for use
imens.
ng well
e with HIV
U ARE:
Not smoking
Eating well
Exercising
Exercising
Call: 1-877-29-HEART
www.reprievetrial.org
Call: 1-877-29-HEART
www.reprievetrial.org
Men and women with HIV are 50–100%
more likely to develop heart disease.
The REPRIEVE clinical research trial may
help people get in front of this problem.
Pitavastatin is a medication approved
for treatment of high cholesterol. In
the REPRIEVE trial, we will test whether
pitavastatin can prevent heart disease in HIV.
You can join the movement to help us
understand whether this drug prevents heart
disease and other chronic complications
among people living with HIV!
What is REPRIEVE?
Am I eligible?
Why should I participate?
REPRIEVE is a clinical research trial testing whether
a daily dose of a statin medication (pitavastatin)
lowers the risk of heart-related disease among
people living with HIV.
•
HIV-positive between ages 40 and 75
By participating in REPRIEVE, you will be:
•
On antiretroviral therapy (ART) for at least 6
months prior to study entry
•
No history of cardiovascular disease
(including heart attack or stroke)
Helping us understand whether pitavastatin
prevents heart-related disease among people
living with HIV.
•
Not currently using a statin drug
LENGTH OF PARTICIPATION
48 months on average
Pay it forward, help to make to make it possible for
people with HIV to live longer and healthier lives.
SIMPLE TIME COMMITMENT
Visits about
3 times per year
THERE’S A SITE NEAR YOU
To learn more about the trial and find a site near
you, visit us at www.reprievetrial.org
Learn more about
the REPRIEVE trial
and how to sign up!
www.reprievetrial.org